← Browse by Condition
Medical Condition

bladder pain syndrome

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 4, Phase 2

Pain clinical trials span acute procedural pain, chronic musculoskeletal pain, neuropathic pain, and cancer-related pain β€” each requiring distinct trial designs and patient-reported outcome instruments. The regulatory demand for non-opioid alternatives has intensified the search for novel analgesic mechanisms, particularly ion channel targets and neurostimulation approaches.

Active trials evaluate Nav1.7/1.8 blockers, CGRP antagonists for new indications, spinal cord stimulation refinements, virtual reality-based pain management, and patient-specific ketamine infusion protocols. Pain trials increasingly use ecological momentary assessment (EMA) diary approaches over traditional recall-based pain rating scales.

Frequently Asked Questions — bladder pain syndrome Clinical Trials

How many clinical trials are currently recruiting for bladder pain syndrome?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for bladder pain syndrome, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for bladder pain syndrome?
bladder pain syndrome research spans Phase 2 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a bladder pain syndrome clinical trial?
Eligibility criteria for bladder pain syndrome trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Phase 4
1
Top Sponsors
Walter Reed National Military Medical Center 1 trial
The Third Affiliated hospital of Zhejiang Chinese Medical University 1 trial
Vaneltix Pharma, Inc. 1 trial
RenJi Hospital 1 trial

Recruiting Clinical Trials

NCT06387329 Phase 4
Recruiting

Bladder Botox UTI Antibiotic Prophylaxis

Enrollment
100 pts
Location
United States
Sponsor
Walter Reed National Military ...
View Trial →
NCT05279963
Recruiting

EA for BPS: An RCT and Study for Central Mechanism

Enrollment
84 pts
Location
China
Sponsor
The Third Affiliated hospital ...
View Trial →
NCT06394830 Phase 2
Recruiting

Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)

Enrollment
50 pts
Location
United States
Sponsor
Vaneltix Pharma, Inc.
View Trial →
NCT06294951
Recruiting

fMRI for BPS: A Descriptive Study of Findings and Symptoms

Enrollment
120 pts
Location
China
Sponsor
RenJi Hospital
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology